COMMUNIQUÉS West-GlobeNewswire

Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen) in the European Union
11/07/2018
CAMBRIDGE, Mass. and CARLSBAD, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), announced [...]
OCHWW looks to the future with appointment of new chief creative officer, Samantha Dolin
11/07/2018
PARSIPPANY, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW; www.ogilvychww.com ), a WPP Health & Wellness company (NYSE:WPP) ( www.wpp.com ), announced today that industry-renowned [...]
Asterias Biotherapeutics Announces Positive Outcome from Safety Review Committee for AST-VAC2; Recommends Continuation of Clinical Trial in Non-Small Cell Lung Cancer (NSCLC)
11/07/2018
FREMONT, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing cellular immunotherapies to treat cancer and cell-based therapeutics [...]
Cara Therapeutics Announces Dosing of Patients in Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin) for Pruritus in Stage III-V Chronic Kidney Disease (CKD) Patients
11/07/2018
Completed Phase 1 trial establishes Oral KORSUVA tablet strengths for treatment of CKD-associated pruritus STAMFORD, Conn., July 11, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical [...]
EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ™ for Posterior Segment Uveitis to be Presented at the 36th Annual Scientific Meeting of the American Society of Retina Specialists
11/07/2018
WATERTOWN, Mass., July 11, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development
11/07/2018
REDWOOD CITY, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created position of Vice [...]
Fourth Published Clinical Trial Confirms Long-Term Safety of NIAGEN® Supplementation at High Doses and Shows Potential for Improvement in Liver Health
11/07/2018
Findings from Aarhus University Hospital and the University of Copenhagen Suggest Further Studies on NIAGEN® Should Focus on Therapeutic Potential for Liver Health IRVINE, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- [...]
Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Nivolumab in Metastatic Colorectal Cancer
11/07/2018
Investigator-led study has commenced dosing Immunotherapy candidate CV301 is being assessed in combination with checkpoint inhibitors in multiple solid tumors COPENHAGEN, Denmark, July 11, 2018 - Bavarian Nordic A/S ( [...]
Wright Medical Group N.V. to Host Second Quarter 2018 Earnings Conference Call
11/07/2018
Wednesday, August 8, 2018, at 3:30 p.m. Central / 4:30 p.m. Eastern AMSTERDAM, The Netherlands, July 11, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced that it will host a conference [...]
Wright Medical Group N.V. Highlights Significant New Product Launches at the American Orthopaedic Foot & Ankle Society (AOFAS) 2018 Annual Meeting
11/07/2018
Company Announces U.S. Launch of PROstep™ Minimally Invasive Surgery System Company Initiates U.S. Commercial Distribution and Sale of AUGMENT ® Injectable Bone Graft AMSTERDAM, The Netherlands, July 11, 2018 (GLOBE [...]
Leading Commercial and Transactional Healthcare Executive Shawn Cline Tomasello Joins Mesoblast Board
11/07/2018
NEW YORK and MELBOURNE, Australia, July 11, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that Shawn Cline Tomasello has joined its Board of Directors. With more than 30 years’ [...]
Virbac : bilan semestriel contrat de liquidité au 30 juin 2018
11/07/2018
Carros, le 10 juillet 2018 BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE Au titre du contrat de liquidité confié par la société VIRBAC S.A. à la société EXANE BNP PARIBAS, les moyens suivants figuraient au [...]
Shire plc : Rule 2.9 Announcement
11/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 July 2018 Shire [...]
Idorsia successfully completes the offering of new shares and the offering of convertible bonds thereby securing long-term funding for the development of its advancing pipeline
11/07/2018
NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATON OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAWS [...]
Achaogen to Host Investor Lunch Updating Investors on Commercial Strategy Post FDA Approval of Plazomicin on July 12th in New York City
10/07/2018
― Key opinion leaders Steven Burdette, M.D., ( Professor of Medicine at Wright State University Boonshoft School of Medicine) and Joshua Rosenberg, M.D. (Chair of Critical Care at The Brooklyn Hospital Center) to [...]
Assure Holdings Corp. Announces Update
10/07/2018
PARKER, Colo., July 10, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is providing an update relating to the appointment of its new auditor and an update relating [...]
Reata Receives Orphan Drug Designation from the European Commission for Omaveloxolone for the Treatment of Friedreich’s Ataxia
10/07/2018
IRVING, Texas, July 10, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced that the European Commission has granted orphan drug designation [...]
CytomX Therapeutics Announces Proposed Public Offering of Common Stock
10/07/2018
SOUTH SAN FRANCISCO, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/07/2018
MENLO PARK, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Pages